Blog + News Announcement Clerkenwell Press Office 08/04/2022 Announcement Clerkenwell Press Office 08/04/2022 Renowned British healthcare leader joins Clerkenwell Health as Therapy Lead Read More Opinion Arda Ozcubukcu 31/03/2022 Opinion Arda Ozcubukcu 31/03/2022 Thou Shalt Not Pass: Solving the Psychedelic Specialist Therapist Bottleneck Read More Opinion Arda Ozcubukcu 09/03/2022 Opinion Arda Ozcubukcu 09/03/2022 The Gold Standard for Psychedelic-Assisted Therapy? Read More Opinion Arda Ozcubukcu 22/11/2021 Opinion Arda Ozcubukcu 22/11/2021 Is the UK an ideal location to run psychedelic trials? Read More Opinion Arda Ozcubukcu 21/09/2021 Opinion Arda Ozcubukcu 21/09/2021 Why Psychedelic Drugs Need Specialist Clinical Research Organisations? Read More Announcement Clerkenwell Press Office 08/09/2021 Announcement Clerkenwell Press Office 08/09/2021 Danish and British Psychedelic Startups Partner to Bring Innovative Psychedelics to Patients Read More Announcement Clerkenwell Press Office 10/08/2021 Announcement Clerkenwell Press Office 10/08/2021 Clerkenwell Partners with Leading Preclinical CRO Transpharmation to Advance Psychedelic Clinical Trials in Europe Read More Announcement Clerkenwell Press Office 07/07/2021 Announcement Clerkenwell Press Office 07/07/2021 Clerkenwell Signs First Multi-Million Pound Contract with International Psychedelic Bio-Tech Company Read More Announcement Clerkenwell Press Office 25/06/2021 Announcement Clerkenwell Press Office 25/06/2021 UK Set To Become Hub Of Psychedelic Research Read More Opinion Arda Ozcubukcu 04/06/2021 Opinion Arda Ozcubukcu 04/06/2021 The psychedelic industry needs data. But what data, and why? Read More Clerkenwell Press Office 01/06/2021 Clerkenwell Press Office 01/06/2021 Psychedelics can open new doors for us, but can we walk through them alone? • Mental Health Today Read More Announcement Clerkenwell Press Office 24/05/2021 Announcement Clerkenwell Press Office 24/05/2021 Meet Our Leadership Team • Clerkenwell Health Read More Newer Posts Older Posts
Announcement Clerkenwell Press Office 08/04/2022 Announcement Clerkenwell Press Office 08/04/2022 Renowned British healthcare leader joins Clerkenwell Health as Therapy Lead Read More
Opinion Arda Ozcubukcu 31/03/2022 Opinion Arda Ozcubukcu 31/03/2022 Thou Shalt Not Pass: Solving the Psychedelic Specialist Therapist Bottleneck Read More
Opinion Arda Ozcubukcu 09/03/2022 Opinion Arda Ozcubukcu 09/03/2022 The Gold Standard for Psychedelic-Assisted Therapy? Read More
Opinion Arda Ozcubukcu 22/11/2021 Opinion Arda Ozcubukcu 22/11/2021 Is the UK an ideal location to run psychedelic trials? Read More
Opinion Arda Ozcubukcu 21/09/2021 Opinion Arda Ozcubukcu 21/09/2021 Why Psychedelic Drugs Need Specialist Clinical Research Organisations? Read More
Announcement Clerkenwell Press Office 08/09/2021 Announcement Clerkenwell Press Office 08/09/2021 Danish and British Psychedelic Startups Partner to Bring Innovative Psychedelics to Patients Read More
Announcement Clerkenwell Press Office 10/08/2021 Announcement Clerkenwell Press Office 10/08/2021 Clerkenwell Partners with Leading Preclinical CRO Transpharmation to Advance Psychedelic Clinical Trials in Europe Read More
Announcement Clerkenwell Press Office 07/07/2021 Announcement Clerkenwell Press Office 07/07/2021 Clerkenwell Signs First Multi-Million Pound Contract with International Psychedelic Bio-Tech Company Read More
Announcement Clerkenwell Press Office 25/06/2021 Announcement Clerkenwell Press Office 25/06/2021 UK Set To Become Hub Of Psychedelic Research Read More
Opinion Arda Ozcubukcu 04/06/2021 Opinion Arda Ozcubukcu 04/06/2021 The psychedelic industry needs data. But what data, and why? Read More
Clerkenwell Press Office 01/06/2021 Clerkenwell Press Office 01/06/2021 Psychedelics can open new doors for us, but can we walk through them alone? • Mental Health Today Read More
Announcement Clerkenwell Press Office 24/05/2021 Announcement Clerkenwell Press Office 24/05/2021 Meet Our Leadership Team • Clerkenwell Health Read More
